MicroRNA-224 is associated with colorectal cancer progression and response to 5-fluorouracil-based chemotherapy by KRAS-dependent and -independent mechanismsMore about Open Access at the Crick
Authors listEB Amankwatia P Chakravarty FA Carey S Weidlich RJC Steele AJ Munro CR Wolf G Smith
Colorectal cancers arise from benign adenomas, although not all adenomas progress to cancer and there are marked interpatient differences in disease progression. We have previously associated KRAS mutations with disease progression and reduced survival in colorectal cancer patients.
Journal British Journal of Cancer
Issue number 9